Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method

Prostaglandins and Other Lipid Mediators

Volumn 58, Issue 5-6, 1999, Pages 253-262

  Mizugakia, Michinao ^a   Hishinuma, Takanori ^a   Matsumura, Emiko ^a   Murai, Yuriko ^a   Yamazaki, Tohru ^a   Yamanobe, Satoshi ^b   Tamai, Makoto ^b  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

GC MS; Prostacyclin; Prostaglandin; Retinal vascular occlusion; Thromboxane

Indexed keywords

ACETYLSALICYLIC ACID; PROSTACYCLIN; THROMBOXANE A2; 11 DEHYDRO THROMBOXANE B2; 11-DEHYDRO-THROMBOXANE B2; 2,3 DINOR 6 KETOPROSTAGLANDIN F1ALPHA; 2,3-DINOR-6-KETOPROSTAGLANDIN F1ALPHA; 6 OXOPROSTAGLANDIN F1 ALPHA; DRUG DERIVATIVE; PROSTAGLANDIN F; THROMBOXANE; THROMBOXANE B2;

ADULT; AGED; ARTICLE; DIAGNOSTIC VALUE; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT MONITORING; RETINA BLOOD VESSEL OCCLUSION; THROMBOSIS; URINE; DOSE RESPONSE; MASS FRAGMENTOGRAPHY; MIDDLE AGED; PILOT STUDY; RETINA ARTERY OCCLUSION; RETINA VEIN OCCLUSION;

6-KETOPROSTAGLANDIN F1 ALPHA; AGED; ASPIRIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOPROSTENOL; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSTAGLANDINS F; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION; THROMBOXANE A2; THROMBOXANE B2; THROMBOXANES;

EID: 0032589564     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(99)00030-1     Document Type: Article

References (29)

1. Graham E.M. The investigation of patients with retinal vascular occlusion. Eye. 4:1990;464-468.
2. Mangat H.S. Retinal artery occlusion. Surv Ophthalmol. 40:1995;145-156.
3. Williamson T.H. Central retinal vein occlusion what's the story? Br J Ophthalmol. 81:1997;698-704.
4. Green W.R., Chan C.C., Hutchins G.M., Terry J.M. Central retinal vein occlusion a prospective histopathologic study of 29 eyes in 28 cases . Retina. 1:1981;27-55.
5. Ishibashi T., Iwasaki M., Ohnishi Y., Inomata H. Pathogenesis of the central retinal vein occlusion. A histopathological study. J Clin Ophthalmol. 38:1984;959-963.
6. Delaney W.V. Jr. Ocular vascular disease in-office primary care diagnosis . Geriatrics. 48:1993;60-66.
7. 2 balance pathophysiological and therapeutic implications . Br Med Bull. 39:1983;271-276.
8. Smith W.L. The eicosanoids and their biochemical mechanisms of action. Biochem J. 259:1989;315-324.
9. Gerritsen M.E. Physiological and pathophysiological roles of eicosanoids in the microcirculation. Cardiovasc Res. 32:1996;720-732.
10. Hirsh P.D., Campbell W.B., Willerson J.T., Hillis L.D. Prostaglandins and ischemic heart disease. Am J Med. 71:1981;1009-1026.
11. FitzGerald G.A., Smith B., Pederson A.K., Brash A.R. Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. N Engl J Med. 310:1984;1065-1069.
12. Goto Y., Tamachi H., Moriguchi E.H. Eicosapentaenoic acid and atherosclerosis. Prostaglandins Leukot Essent Fatty Acids. 48:1993;337-342.
13. Dollery CT, Friedman LA, Hensby CN, et al. Circulating prostacyclin may be reduced in diabetes. Lancet 1979;ii:1365.
14. Moreno A., La Cruz J.P., Campos J.G., Cuesta S. Prostacyclin-thromboxane balance and retinal vascular pattern in rats with experimentally induced diabetes. Can J Ophthalmol. 30:1995;117-123.
15. Davis T.M.E., Mitchell M.D., Turner R.C. Prostacyclin and thromboxane metabolites in diabetes. Lancet. 13:1979;789-790.
16. Hishinuma T., Yu G.S.P., Takabatake M., et al. Analysis of the thromboxane/prostacyclin balance in human urine by gas chromatography/selected ion monitoring abnormalities in diabetics . Prostaglandins Leukot Essent Fatty Acids. 54:1996;445-449.
17. 2/prostacyclin ratio in urine of diabetic mice analyzed by gas chromatography/selected ion monitoring. Prostaglandins & other Lipid Mediators. 55:1998;83-93.
18. 2 in patients with occluded retinal vein using GC/SIM. Prostaglandins Leukot Essent Fatty Acids. 58:1998;65-68.
19. 2) and its application to gas chromatographic analysis of fatty acids. Chem Pharm Bull. 29:1981;1475-1478.
20. 1α in human urine using gas chromatography/high resolution-selected ion monitoring. J Chromatogr. 658:1994;11-19.
21. 2-labeled analog as an internal standard. Biol Mass Spectrom. 23:1994;612-620.
22. Haeffliger I.O., Meyer P., Flammer J., Luscher T.F. The vascular endothelium as a regulator of the ocular circulation a new concept in ophthalmology? Surv Ophthalmol. 39:1994;123-132.
23. 1α in healthy subjects . Biochim Biophys Acta. 1133:1992;247-254.
24. Vane J.R., Botting R.M. Heart disease, aspirin, and fish oil. Circulation. 84:1991;2588-2599.
25. Abe M., Atsumi O., Mikami T., Yoshimoto H. Platelet inhibitory effect of low dose aspirin in retinal circulatory disorders. Jpn J Clin Ophthalmol. 43:1989;327-330.
26. Fujiwara H., Fukutomi T., Katayama T., Sakamoto T. Study on the pharmacological effects of prostaglandin E1 (PGE1) on the human eye. Report 2. Analysis of effect of PGE1 on human retinal vessels. Nippon Ganka Gakkai Zasshi. 90:1986;393-399.
27. Idegami D., Matsuo N., Eguchi K., Kitajima N., Kishimoto N. Treatment of central retinal artery occlusion with hyperbaric oxygenation, cervical continuous epidual blocking and intravenous drip infusion of prostaglandin E1. J Eye. 5:1988;107-110.
28. Hammes H.P., Weiss A., Fuhrer D., Kramer H.J., Oaoavassukus C., Grimminger F. Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids. Diabetologia. 39:1996;251-255.
29. 2 synthetase inhibitor. J Int Med Res. 25:1997;108-111.